Emetogenic chemotherapy regimens and back pain were associated with higher symptom burden in older, vs younger, patients with ...

When treating patients with hormone-receptor positive, HER2-negative metastatic breast cancer, mutations necessitate the ...

Apalutamide decreased risk of death in mCSPC by 23% and 26% compared with enzalutamide and abiraterone acetate, respectively.

The MindCap mobile app is likely feasible as an assessment for cognitive function of cancer survivors, although further data ...

The PRECURSOR intervention appeared feasible/acceptable, suggesting a need for patient-centered conversation in incurable ...

Sessions addressing supportive care needs for patients with cancer on early phase clinical trials appeared feasible and ...

Oncology nurses can support patients facing financial toxicity by offering guidance on available resources and providing ...

Tara Sweeney, BSN, RN, OCN, CHPN discussed best care for the health and well-being of a person across all stages of their ...

Panelists discuss how cardiovascular toxicity remains a significant concern with certain tyrosine kinase inhibitors (TKIs) used in chronic myeloid leukemia (CML) treatment, particularly with the older ...

Providing education about patients’ diseases was difficult, according to 32% of registered nurses and 29% of infusion nurses.

Panelists discuss how eliminating the strict mealtime restrictions with the new nilotinib formulation addresses a significant unmet need in chronic myeloid leukemia (CML) treatment by reducing ...

The FDA has granted approval to nivolumab plus ipilimumab for use in unresectable or metastatic hepatocellular carcinoma.